Alopecia areata GLYCOGEN STORAGE DISEASE Ia; GSD1A
Intracranial aneurysm GLYCOGEN STORAGE DISEASE II; GSD2
Rheumatoid arthritis HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2
Chronic bronchitis and chronic obstructive pulmonary disease HERMANSKY-PUDLAK SYNDROME 3; HPS3
Breast cancer GWAS HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME
Breast Cancer: pathogenic SNP carrier ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED
Ovarian cancer in BRCA1 mutation carriers JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1
Prostate cancer JOUBERT SYNDROME 14; JBTS14
Prostate cancer aggressiveness JOUBERT SYNDROME 16; JBTS16
Prostate cancer (early onset) JOUBERT SYNDROME 3; JBTS3
Bladder cancer JOUBERT SYNDROME 5; JBTS5
Upper aerodigestive tract cancers JOUBERT SYNDROME 7; JBTS7
Basal cell carcinoma JOUBERT SYNDROME 8; JBTS8
Motion sickness JOUBERT SYNDROME 9; JBTS9
Primary biliary cirrhosis KABUKI SYNDROME 1; KABUK1
Age-related macular degeneration LEIGH SYNDROME; LS
Conduct disorder LEOPARD SYNDROME 1; LPRD1
Type 1 diabetes LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM
Type 1 diabetes nephropathy LISSENCEPHALY 1; LIS1
Type 2 diabetes LOEYS-DIETZ SYNDROME 2; LDS2
Endometriosis LONG QT SYNDROME 1; LQT1
Celiac disease LYNCH SYNDROME I
Alzheimer’s disease (late onset) MAPLE SYRUP URINE DISEASE; MSUD
Coronary heart disease MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2
Parkinson’s disease MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
Multiple sclerosis MECKEL SYNDROME, TYPE 3; MKS3
Systemic sclerosis MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH
Schizophrenia METACHROMATIC LEUKODYSTROPHY; MLD
Glioma METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
Hypothyroidism METHYLMALONIC ACIDURIA, cblA TYPE
Myocardial infarction (early onset) METHYLMALONIC ACIDURIA, cblB TYPE
Chronic lymphocytic leukemia MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1
Hodgkin’s lymphoma MUCOPOLYSACCHARIDOSIS TYPE VI; MPS6
Diffuse large B cell lymphoma MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7
Follicular lymphoma MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A
Myasthenia gravis MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B
Multiple myeloma MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A
Neuroblastoma MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1
Osteosarcoma MYOPATHY, MYOFIBRILLAR, 1; MFM1
Psoriasis MYOPATHY, CENTRONUCLEAR, 1; CNM1
Allergic sensitization MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX
Testicular germ cell tumor NEMALINE MYOPATHY 2; NEM2
Wilms tumor CYSTINOSIS, NEPHROPATHIC; CTNS
Vitiligo NIEMANN-PICK DISEASE, TYPE C1; NPC1
17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY NIEMANN-PICK DISEASE, TYPE A
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D NIEMANN-PICK DISEASE, TYPE B
AARSKOG-SCOTT SYNDROME; AAS NOONAN SYNDROME 1; NS1
ACHROMATOPSIA 2; ACHM2 NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL
LEUKEMIA, ACUTE MYELOID; AML NOONAN SYNDROME 4; NS4
ADRENOLEUKODYSTROPHY; ALD Obesity due to melanocortin 4 receptor deficiency
HYPOPHOSPHATASIA, ADULT ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B
ALLAN-HERNDON-DUDLEY SYNDROME; AHDS OSTEOGENESIS IMPERFECTA, TYPE III; OI3
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD DIABETES MELLITUS, PERMANENT NEONATAL; PNDM
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED PITT-HOPKINS SYNDROME; PTHS
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP
ANGELMAN SYNDROME; AS MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5
ANTITHROMBIN III DEFICIENCY; AT3D RETINITIS PIGMENTOSA; RP
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10 RUBINSTEIN-TAYBI SYNDROME 1; RSTS1
AURICULOCONDYLAR SYNDROME 1; ARCND1 SOTOS SYNDROME 1; SOTOS1
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR SUPRAVALVULAR AORTIC STENOSIS; SVAS
BARDET-BIEDL SYNDROME 1; BBS1 TAY-SACHS DISEASE; TSD
MUSCULAR DYSTROPHY, BECKER TYPE; BMD TUBEROUS SCLEROSIS 1; TSC1
BETA-THALASSEMIA TUBEROUS SCLEROSIS 2; TSC2
BLOOM SYNDROME; BLM ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A
BRUGADA SYNDROME 1; BRGDA1 TYROSINEMIA, TYPE I; TYRSN1
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1 USHER SYNDROME, TYPE I; USH1
CARDIOMYOPATHY, DILATED, 1S; CMD1S USHER SYNDROME, TYPE ID; USH1D
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1 USHER SYNDROME, TYPE IF; USH1F
CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1 USHER SYNDROME, TYPE IIA; USH2A
CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7 USHER SYNDROME, TYPE IIC; USH2C
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C USHER SYNDROME, TYPE IID; USH2D
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1 USHER SYNDROME, TYPE IIIA; USH3A
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD
ADRENAL HYPOPLASIA, CONGENITAL; AHC VON HIPPEL-LINDAU SYNDROME; VHL
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C WEAVER SYNDROME; WVS
CORNELIA DE LANGE SYNDROME 1; CDLS1 Wilson Disease
COSTELLO SYNDROME; CSTLO AGAMMAGLOBULINEMIA, X-LINKED; XLA
CYSTIC FIBROSIS; CF
DANON DISEASE
DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A
DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31
DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7
DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9
MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA
CARDIOMYOPATHY, DILATED, 1A; CMD1A
DUBIN-JOHNSON SYNDROME; DJS
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2
MYOCLONIC EPILEPSY OF LAFORA
ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2
FABRY DISEASE
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2
FAMILIAL MEDITERRANEAN FEVER; FMF
THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC
FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO
NEPHROTIC SYNDROME, TYPE 1; NPHS1
GAUCHER DISEASE, TYPE I
GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1
GLUTARIC ACIDEMIA I; GA1
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD